Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China
2022-03-30 08:05
Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential
2022-03-30 08:00
Innovent Announced 2021 Annual Results
2022-03-30 08:00
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines
2022-03-29 09:00
Innovent Announces First Patient Dosing of Claudin18.2/CD3 Bispecific Antibody IBI389 in Phase 1a/1b Clinical Trial for Advanced Solid Tumor
2022-03-29 08:10
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®
2022-03-29 07:39
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2021
2022-03-29 06:30
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%
2022-03-29 01:01
Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany
2022-03-28 21:30
Hyperflex® Balloon Catheter by Endovastec™ Receives Marketing Approval in Japan
2022-03-28 12:29
Innovent and Lilly Expand Strategic Partnership in Oncology
2022-03-28 08:00
Ascletis Announces the Latest Results of the Preclinical Studies of Two Novel Anti-Cancer Drug Candidates, ASC61 and ASC60, to be presented at AACR Annual Meeting 2022
2022-03-27 18:30
Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG
2022-03-25 21:24
Abcam the most awarded company at 2022 industry awards
2022-03-25 20:40
Modern Chinese Medicine Announces Year 2021 Annual Results
2022-03-25 10:39
Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets
2022-03-24 21:00
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care
2022-03-24 07:00
Fosun International Announces 2021 Annual Results: Total Revenue Increased by 18% to RMB161.29 Billion, Striving to Pursue Steady and Sustainable Development
2022-03-23 23:01
Telix Advances Development of Glioblastoma Therapy Program
2022-03-23 10:16
Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India
2022-03-23 09:31
1
82
83
84
85
86
229